(TSH), is composed of two distinct non-covalently associated subunits, namely the α-and β-subunits. Intact HCG, i.e. (Bousfield et al., 1994) . 3 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Clinic of Infertility and It is generally accepted that the dimer HCG (α-and β-Gynaecological Endocrinology, WHO Collaborating Center in subunits) structure changes during pregnancy with a higher Human Reproduction, University Hospital of Geneva, 32 Blvd de la molecular weight (Fein et al., 1980) or sialic acid content Cluse, 1211 Geneva 14, Switzerland. ( Wide and Hobson, 1987) during the first trimester compared E-mail: Pascal.Mock@hcuge.ch to late pregnancy. A change in the nature of several HCG The objective of this study was to evaluate the distribution isoforms seems to occur at around the 13th week of gestation of choriocarcinoma-like human chorionic gonadotrophin with the appearance of less acidic HCG molecules later in (HCG) isoforms during first trimester pregnancy and their pregnancy (Wide et al., 1994) . Whereas nicked HCG (HCGn, relationship with in-vitro HCG bioactivity. This was done peptide bond cleavages within its β-subunit loop 2) was by means of a retrospective analysis of patients' sera with considered by previous reports as more prevalent after 8-10 first trimester normal intrauterine and abnormal (ectopic) weeks of pregnancy (Cole et al., 1993; O'Connor et al., 1994), pregnancies. Serum samples were obtained from 38 women it appears recently that HCGn is not produced in significant with an amenorrhoea of <10 weeks. From these, 19 had a quantities during normal pregnancy (Kovalevskaya et al., normal intrauterine pregnancy (IUP) and 19 an ectopic 1999a).
to late pregnancy. A change in the nature of several HCG The objective of this study was to evaluate the distribution isoforms seems to occur at around the 13th week of gestation of choriocarcinoma-like human chorionic gonadotrophin with the appearance of less acidic HCG molecules later in (HCG) isoforms during first trimester pregnancy and their pregnancy (Wide et al., 1994) . Whereas nicked HCG (HCGn, relationship with in-vitro HCG bioactivity. This was done peptide bond cleavages within its β-subunit loop 2) was by means of a retrospective analysis of patients' sera with considered by previous reports as more prevalent after 8-10 first trimester normal intrauterine and abnormal (ectopic) weeks of pregnancy (Cole et al., 1993; O'Connor et al., 1994) , pregnancies. Serum samples were obtained from 38 women it appears recently that HCGn is not produced in significant with an amenorrhoea of <10 weeks. From these, 19 had a quantities during normal pregnancy (Kovalevskaya et al., normal intrauterine pregnancy (IUP) and 19 an ectopic 1999a).
pregnancy (EP). Total immunoreactive HCG (HCGi), free
Several studies have demonstrated for HCG as well as for β-HCGi and oestradiol were measured by enzyme immunothe other gonadotrophins that the biological activity of the assays and bioactive HCG by the mouse Leydig cell bioasmolecule may be influenced by its sialic acid content (Wide, say. The alterations in HCG isoform content were measured 1962; Wide and Hobson 1987; Burgon et al., 1996 Burgon et al., , 1997 ; by the combination of two immunometric assays, B152 Stanton et al., 1996; Ronco et al., 1998) or glycans (Matzuck for choriocarcinoma-like HCG and B109 for intact HCG et al., 1989; Nemansky et al., 1995; Heikoop et al., 1998) or detection and expressed as the B152/B109 ratio. Choriocareven by the presence of peptide cleavage as in the nicked cinoma-like HCG isoforms ratio measured by B152 and HCG (Cole et al., 1991) .
B109 assays was significantly higher in the low subgroups
While most studies reported a difference in HCG bioactivity of free β-HCGi and gestational age (P ⍧ 0.0111 and 0.0036 between the first and the last trimester of pregnancy which respectively). Whereas bioactive to immunoreactive HCG seems to be related to the above-mentioned HCG structural ratios (b/i ratio) were significantly higher when free β-change, it was reported recently that a modulation of HCG HCGi concentrations were low (P ⍧ 0.0010), no correlation bioactivity exists already during the early phase of placental was found between the variation of bioactivity (b/i ratio) development (amenorrhoea Ͻ10 weeks) in normal and abnorand the proportion of choriocarcinoma-like HCG isoforms (B159/B108). It is concluded that in first trimester pregnanmal pregnancies (Mock et al., 1998) .
cies (i) the modulation of HCG in-vitro bioactivity is
Interestingly, a recent study including IVF patients demonnot related to the variation of choriocarcinoma-like HCG strated that there were similar progressive changes of HCG isoforms secretion and (ii) the amount of choriocarcinomaisoforms from 1 to 4 weeks post-embryo transfer and progresslike HCG isoforms secreted by the early trophoblast is ively afterwards (Kovalevskaya et al., 1999b) . These authors predominant and may be the result of an early developused a new immunoradiometric assay (IRMA) based on a mental regulation of glycosylation enzyme.
monoclonal antibody which detect choriocarcinoma-like HCG. Key words: bioactivity/choriocarcinoma/HCG/monoclonal This assay appears to be particularly sensitive to changes in antibodies/pregnancy carbohydrate structure and to detect HCG isoforms present during early gestation (O'Connor et al., 1998) . Since the importance of oligosaccharides for the biological Introduction activity of HCG and other gonadotrophins is well established (Thotakura and Blithe, 1995) , it is postulated that HCG Human chorionic gonadotrophin (HCG), a member of the glycoprotein hormone family which includes pituitary horisoforms secreted in early pregnancy such as choriocarcinoma-like HCG known to have highly branched oligosaccharides (Elliott et al., 1997) may be related to our recent observation of HCG bioactivity modifications. The aim of this study, therefore, was to analyse the relationship between both invitro bioactivity and these specific HCG isoforms.
Materials and methods
Only women (n ϭ 38) with amenorrhoea of Ͻ10 weeks were included in this study. Among these, 19 patients had a normal intrauterine pregnancy (IUP), 19 women had an ectopic pregnancy (EP) of similar gestational age (mean: 43.6 and 46.6 days respectively). EP were diagnosed by laparoscopy and were all tubal pregnancies. IUP were confirmed by first trimester transvaginal echography and all cases of IUP had a normal term delivery. Serum samples were obtained (one sample per patient) at the time Figure 1 . Comparison of human chorionic gonadotrophin (HCG) isoforms ratios measured by the B152-B207* and B109-B108* of echographic diagnosis in normal IUP or at the day of laparoscopy assays and HCG bioactive/immunoreactive (b/i) ratios in serum of in the EP. Immunoreactive free β-HCG was measured by radiofirst trimester pregnancies (n ϭ 38) between low and high immunoassay (free β-HCG; CISbio International, Saclay, France) and subgroups of free β-HCGi irrespective of the implantation site. total immunoreactive HCG by enzyme immunoassay (total HCG IMX; Abbott Abbott Park, USA) at a sensitivity of 0.1 ng/ml and 1 mIU/ml respectively. Oestradiol was measured by an automated proportion of choriocarcinoma-like HCG isoforms (B152/ enzyme immunoassay (Vidas; Biomérieux, Marcy-l'Etoile, France) B109) and HCG bioactivity were significantly higher in the at a sensitivity of 5 pg/ml. low free β-HCGi subgroup. However, there was no correlation Bioactive HCG (HCGb) was measured in triplicate by a mouse between B152/B109 and HCG b/i ratios (result not shown).
Leydig cell bioassay (Robertson and Binden, 1990) as recently
Furthermore, whereas the b/i ratio decreased with increasing described (Mock et al., 1998). immunoreative free β-HCGi (r 2 ϭ 0.38, P Ͻ 0.0001), B152/ Immunoradiometric assays B109-B108* and B152-B207* were B109 tended only to be inversely correlated without reaching used to measure intact HCG as previously described (O'Connor et al., statistical significance (r 2 ϭ 0.10, P ϭ 0.0574). B152/B109 1988, 1998) .
The first antibody was the capture antibody, the second with an was not correlated to HCGi nor HCGb or serum oestradiol.
asterisk, was a radioiodinated detection antibody. The antibody, B152,
The proportion of HCG isoforms measured by B152 and was developed by using as immunogen a hyperglycosylated and B109 assays (B152/B109) was evaluated according to the 100% nicked form of HCG produced by a single individual with concentrations of free β-HCGi, total HCGi, oestradiol and choriocarcinoma (Birken et al., 1999) . The B152 assay appears to be gestational age in all first-trimester pregnancies. B152/B109
sensitive to changes in carbohydrate structure and can measure very ratios were stratified in two subgroups (low or high) according early isoforms of HCG (O'Connor et al., 1998) , whereas the B109 to: (i) immunoreactive free β-HCG (free β-HCGi) Ͻ10 ng/ml assay detects isoforms of HCG which predominate later in pregnancy (low; mean 2.9, range 0.8-8.2) and Ͼ10 ng/ml (high; mean (Kovalevskaya et al., 1999b) . Since the B152 assay detects with 49.8, range 10-105), (ii) total HCG immunoreactivity Ͻ5000 greatly enhanced sensitivity HCG isoforms which appear earlier in mIU/ml (low; mean 1580, range 175-3849) and ജ5000 mIU/ pregnancy than isoforms measured by the B109 assay, the alteration ml (high; mean 49 689, range 8110-127 820), (iii) serum of the B152/B109 ratio, as used in the present study, was assumed to reflect HCG isoforms change. Intra-assay variation was 6% for oestradiol Ͻ300 ng/ml (low; mean 155, range 38-298) and both assays, inter-assay variation was 12% for B109-B108* and 13% ജ300 ng/ml (high; mean 562, range 307-1123) and finally (iv)
for B152-B207* assays. Sensitivity (least detectable dose) defined as gestational age Ͻ40 days (low; mean 36, range 32-39) and ϩ2 SD from the zero calibrator, was 1.0 fmol/ml for the B109-B108* ജ40 days (high; mean 48, range 40-66). As shown in Figure 2 , assay and 2.2 fmol/ml for the B152-B207* assay.
B152/B109 ratios showed only a trend to be lower in high
Results were stratified in two subgroups (low and high) according subgroups of total HCGi and serum oestradiol, whereas there to immunoreactive free β-HCG (free β-HCGi), total HCG immunowas a strong significant difference between both subgroups reactivity, serum oestradiol and gestational age.
for gestational age (P ϭ 0.0036) and free β-HCGi. Interestingly, Statistical analyses were performed on a Power Macintosh computer GA was closely correlated to oestradiol and free β-HCGi in using the Statview programme. Data were compared by analysis of IUP only (r 2 ϭ 0.33, P ϭ 0.0153 and r 2 ϭ 0.41, P ϭ 0.0059).
variance (ANOVA) or unpaired Student's t-test when appropriate.
However, while there was no correlation between b/i ratio and gestational age, there was a strong negative correlation between Results B152/B109 ratios and gestational age for cases between 32 and 50 days of last menstrual period irrespective of the Figure 1 compares the ratio of HCG isoforms measured by B152 and B109 assays (B152/B109) and HCG b/i ratios implantation site as shown in Figure 3 . A similar comparison of parameters in both IUP and EP is between low and high subgroups of free β-HCGi for all pregnancies irrespective of their site of implantation. B152/ shown in Table I . Using an analysis of variance with Scheffé's test, there was no difference in the gestational age between B109 and HCG b/i ratios were different between both subgroups (P ϭ 0.0111 and P ϭ 0.0010 respectively). Both the the different subgroups. Stratifying the data according to the Comparison of B152/B109 ratios between high and low subgroups according to free β-HCGi, total HCGi, oestradiol and gestational age in first-trimester pregnancies (n ϭ 38). NS ϭ not significant.
negatively correlated to oestradiol (r 2 ϭ 0.363, P Ͻ 0.0001), B152/B109 was not correlated to oestradiol (results not shown).
Discussion
The results of the present study indicate that the secretion profile of choriocarcinoma-like HCG isoforms, using B152 and B109 IRMA (B152/B109), changes in the maternal circulation during spontaneous first-trimester pregnancy. The distribution of these isoforms follows throughout early pregnancy a similar pattern to HCG bioactivity and is independent of the implantation site. However, no correlation was found between these choriocarcinoma-like HCG (B152/B109) and b/i ratios and serum oestradiol. It appears that these parallel modifications in HCG structure and bioactivity have never been reported in the literature in early spontaneous pregnancy. While most studies were focused on a difference of HCG altered already in first-trimester pregnancies (Mock et al., 1998) . It was postulated that such a modification may be causally related to HCG isoform changes. Carbohydrate moisite of implantation, it was observed that in IUP and EP, the b/i ratio decreased significantly with increasing free β-HCGi, eties such as glycans (oligosaccharides) and sialic acid are directly implicated in various molecular forms of HCG or whereas the B152/B109 ratio showed only a trend to decrease (not significant, Table I ). There was no difference in either other gonadotrophins and they appear to be related to the bioactivity (for reviews, see Thotakura et al., 1990 ; Thotakura HCG b/i nor B152/B109 ratios between matched IUP and EP subgroups. Values of free β-HCGi were not different when and Blithe, 1995). Indeed, N-linked oligosaccharides on the α chain (Asn 52) of HCG seem to play an important role in comparing matched IUP and EP subgroups. However, oestradiol concentrations were significantly different between the signal transduction, resulting in a stimulation of steroidogenesis and cAMP production (Matzuck et al., 1989) . A linear correladifferent free β-HCGi subgroups for both IUP and EP (P Ͻ 0.0001). Moreover, EP had significantly (P ϭ 0.0026) lower tion has been demonstrated for human FSH between sialic acid content, radioreceptor activity and in-vitro bioactivity oestradiol concentrations than IUP except when the lower subgroups were compared. Whereas b/i ratios appeared to be . NS ϭ not significant. Statistics for b/i: in IUP: low versus high, P ϭ 0.0141; in EP: low versus high, P ϭ 0.0043. Statistics for gestational age: IUP low versus EP low P ϭ NS, IUP high versus EP high P ϭ NS. Statistics for B152/B109: in IUP: low versus high, P ϭ NS; in EP: low versus high, P ϭ NS.
HCG isoforms secreted by choriocarcinoma have highly increased secretion of HCG is commonly used as an indicator branched oligosaccharides (Elliot et al., 1997) . Recently, simof syncytiotrophoblast formation in in-vitro cytotrophoblast ilar HCG isoforms have been detected in early pregnancy by cultures (Kliman et al., 1986) . During the first trimester of an immunoradiometric assay B152 (O'Connor et al., 1998;  gestation, free β-HCG and HCG dimer immunoreactivity Kovalevskaya et al., 1999b) . Indeed, it has been demonstrated follow a similar pattern of secretion with a serum peak that the distribution of the choriocarcinoma-like HCG isoforms occurring between 8-10 weeks (Ozturk et al., 1988) . Therefore, synthesized by the JAR choriocarcinoma cell lines and measin early gestation when a low amount of free β-HCG and ured by B152/B109 assays ratio was similar to that observed HCG dimer are secreted by the trophoblast, trophoblast tissue in early pregnancy. However, the structure of B152 recognized may also be considered as less differentiated. It is postulated isoforms from early pregnancy has not yet been characterized that in early gestational trophoblast as well as in choriocarcinand it is not clear whether these isoforms may be considered oma, both considered as less differentiated tissues, some as having highly branched oligosaccharides residues and/or as enzymatic alteration may lead to the biosynthesis of highly being acidic isoforms with a high sialic acid content.
branched N-linked oligosaccharide. Thus, the higher proportion Interestingly, a recent report studied the different HCG of choriocarcinoma-like HCG isoforms during early gestation, isoforms during early human embryo development in an IVF decreasing progressively with advancing gestational age, could programme. It was demonstrated that early blastocyst (day 11 be explained by incomplete glycosylation processing. Another after fertilization) produced more acidic HCG isoforms than explanation may be related to the highly proliferative pattern of the more advanced embryos (day 14). These results suggest trophoblast tissue as choriocarcinoma or villous cytotrophoblast that the bioactivity of HCG secreted by the blastocysts may cells. Indeed, it has been demonstrated in yeast that Nchange with time and with the differentiation of the trophectodglycosylation genes, in particular the dolichol pathways ALG erm (Lopata et al., 1997) .
genes, play a central role in the cellular cycle (for review, see The observation in the current study that there is a similar Kukurinska and Lennon, 1999) . The expression of ALG 7, the decrease of secreted choriocarcinoma-like HCG isoforms and first gene in the dolichol pathway of N-glycosylation protein HCG bioactivity with increasing amount of free β-HCG synthesis, is down-regulated in cell-cycle arrest and may be immunoreactivity may well correspond to the in-vitro HCG involved in the down-regulation of cyclin expression (Lennon isoform pattern found for cultured blastocyst. However, et al., 1997) . Thus, differentiation of trophoblast with advanbecause no correlation was found between B152/B109 isoforms cing gestational age, which is accompanied by cell-cycle arrest ratio and HCG bioactivity, the direct implication of choriocarci-(syncytium formation), may contribute to an alteration of HCG noma-like HCG on HCG in-vitro bioactivity can be ruled out.
N-glycosylation. Taken together, the observations of the current Because monoclonal antibody B152 preferentially binds to study that there was a higher proportion of choriocarcinomahyperglycosylated HCG isoforms, but not to those with sialic like HCG isoforms when HCG secretion was low may be thus acid differences (Birken et al., 1999) , it is postulated that the explained and/or related to the incomplete differentiation of observed alteration of B152/B109 ratio during early pregnancy trophoblast tissue as found during its early development. Since is related to a modulation of other HCG molecular isoforms early cytotrophoblasts before the 6th week of gestation appear such as sialic acid content which are prone to influence HCG to secrete dimer HCG (Maruo et al., 1992) , choriocarcinomabioactivity.
like HCG isoforms may be even related to the secretion of In the current study, it appears that the distribution of this area of villous trophoblast. Thereafter, as syncytialization choriocarcinoma-like HCG isoforms (B152/B109) is related of trophoblast is increasing during the first trimester and to free β-HCG immunoreactivity and gestational age. This promoted by HCG (Shi et al., 1993) , differentiated syncytiotrofinding strongly suggests that these specific isoforms are related to the differentiation process of trophoblastic tissue. Indeed, phoblasts may thus secrete more well processed glycosylated
